Neurological

The Mountain View, CA-based company has developed the RNS System, a closed-loop, brain-responsive neurostimulation system that was designed to prevent epileptic seizures by stopping them at the source.

Medtronic CEO Geoff Martha says the company is becoming a more nimble and a more competitive organization.

FDA approved Medtronic's rechargeable device to deliver sacral neuromodulation therapy for the treatment of overactive bladder, fecal incontinence, and non-obstructive urinary retention.

The Irvine, CA-based company said at two years, about 80% of patients in the ARTISAN-SNM study achieved greater than or equal to 75% improvement, with 37% being completely dry.

CereVasc raised $43.9 million in series A financing to support the development of a minimally invasive alternative for hydrocephalus, a condition sometimes called "water on the brain."

The deal is "far from a certainty" at this point, but a LivaNova buyout could be good news for Medtronic's neuromodulation business.

Medtronic CEO Omar Ishrak has been heard many times this year saying that the company is enjoying the strongest product pipeline in its history. Here's why.